| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_deff0ab87e07d714dcf3d03223972069 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4721
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 |
| filingDate |
1991-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c4dc202dfb6f9243cd6d9235a9eaa60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf7e60d093b92fa4bcd4aa1eeb479d71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2dc2684a10b4562d984f004ac5a7ae00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2aaa6a12b87401501f1d078ba49dfe0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_105b73b8f9bfbec9d789dadcd178ade2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fc40b92b204fbab5dce44dabbba71f1 |
| publicationDate |
1992-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0496013-A1 |
| titleOfInvention |
Synthetic peptide derived from human lipocortin V and use thereof |
| abstract |
The synthetic peptide of formula (I) H-Ser-His-Leu-Arg-Lys-Val-Phe-Asp-Lys-OH and its physiologically acceptable organic or inorganic salts are novel. The synthetic peptide (I), whose amino acid sequence corresponds to that of the sequence 204-212 of human lipocortin V, shows in vitro the capability of inhibiting the prostaglandin E2 release and in vivo an antiinflammatory activity. Said peptide and its organic and inorganic salts are useful as therapeutic agents for the treatment of dermatological and collagen inflammatory infections. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2349321-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9192649-B2 |
| priorityDate |
1991-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |